|
Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010 to 2017 |
Sep 1 2017 |
614 |
Global |
$2,995.00 |
|
|
Global Gastrointestinal Symptoms Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Infectious Vaccines Partnering Terms and Agreements 2010 to 2017: Deal trends, players and financials |
Sep 1 2017 |
457 |
Global |
$2,995.00 |
|
|
Targacept Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Obstetrics Partnering 2010-2017: Deal trends, players and financials |
Sep 1 2017 |
200 |
Global |
$2,995.00 |
|
|
Global Parasitic Disease Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Eli Lilly Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Acute and Chronic Myelogenous Leukemia Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Beiersdorf Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Dementia Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Multiple Sclerosis Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Global Sexual Dysfunction Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Questcor Pharmaceuticals Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Oncology Partnering 2010-2017: Deal trends, players and financials |
Sep 1 2017 |
5000 |
Global |
$3,495.00 |
|
|
Global Anemia Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Global Brain Cancer Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Alcon Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Lysosomal Storage Disease Partnering 2010-2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
GlaxoSmithKline Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 |
Sep 1 2017 |
280 |
Global |
$1,995.00 |
|
|
Global Inflammatory Bowel Disease Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global In Vitro Diagnostics Partnering 2010-2017: Deal trends, players, financials and forecasts |
Sep 1 2017 |
660 |
Global |
$2,995.00 |
|
|
Syngenta Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Metabolic Partnering 2010-2017: Deal trends, players and financials |
Sep 1 2017 |
500 |
Global |
$2,995.00 |
|
|
Global HIV Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Eisai Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Solid Tumor Partnering 2010 to 2017 |
Sep 1 2017 |
150 |
Global |
$1,495.00 |
|
|
Baxter Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Global Depression Partnering 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
|
Merck KGaA / Merck Serono Partnering Deals and Alliances 2010 to 2017 |
Sep 1 2017 |
100 |
Global |
$1,495.00 |
|
